European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy (EuLITE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00700531|
Recruitment Status : Completed
First Posted : June 18, 2008
Last Update Posted : October 5, 2016
University Hospital Birmingham
Gambro Renal Products, Inc.
Ortho Biotech, Inc.
Information provided by (Responsible Party):
Paul Cockwell, University Hospital Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Completed|
|Actual Primary Completion Date :||January 2014|
|Actual Study Completion Date :||October 2015|
Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol. 2007 Mar;18(3):886-95. Epub 2007 Jan 17.
Hutchison CA, Harding S, Mead G, Goehl H, Storr M, Bradwell A, Cockwell P. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care. Artif Organs. 2008 Dec;32(12):910-7. doi: 10.1111/j.1525-1594.2008.00653.x.